Ciclopirox olamine induces ferritinophagy and reduces cyst burden in polycystic kidney disease
Despite the recent launch of tolvaptan, the search for safer polycystic kidney disease (PKD) drugs continues. Ciclopirox (CPX) or its olamine salt (CPX-O) is contained in a number of commercially available antifungal agents. CPX is also reported to possess anticancer activity. Several mechanisms of...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
American Society for Clinical investigation
2021-04-01
|
| Ráidu: | JCI Insight |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1172/jci.insight.141299 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|